课题基金 / 基金详情

Development of novel eye illumination methods for ophthalmology

Development of novel eye illumination methods for ophthalmology
眼科新型眼睛照明方法的开发
批准号:
413198-2011
负责人:
BrundelRe, Riccardo
金额:
$1.82万
依托单位国家:
加拿大
项目类别:
Applied Research and Development Grants - Level 1
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-01-01 至 2012-12-31

项目摘要

项目成果

BrundelRe, Riccardo的其他基金

相似基金

相关文献

中文摘要
翻译
Annidis RHA系统是一款先进的多光谱成像检眼镜,可用于早期检测老年性黄斑变性和青光眼等眼部疾病。提出了一种新的眼后脉络膜照明方法,并将其作为进一步发展该系统的主要研究方向。与通过眼睛瞳孔的标准照明相反,由Annidis Health Systems和阿尔冈昆学院合作开发的这一新方案利用眼睛组织的波导性和其他特性将光线投射到脉络膜上。这项技术可能会让眼科和验光在诊断/发现与视力相关的问题和疾病方面具有令人大开眼界的可能性。这项研究将促进新一代数字检眼镜的开发和商业化。渥太华的合作伙伴公司Annidis将加强其作为该领域创新和市场领导者的地位,从而为一家加拿大公司增加收入和创造就业机会。
英文摘要
The Annidis RHA system is an advanced Multi-Spectral Imaging ophthalmoscope for early detection of ocular pathologies such as age-related macular degeneration and glaucoma. A new method of illumination of the choroid at the back of the eye is proposed and will be studied as a major prospect for developing the system further. Contrary to the standard illumination through the pupil of the eye, the novel scheme, developed in collaboration by Annidis Health Systems and Algonquin College, uses waveguiding and other properties of the eye tissues to cast light on the choroid. This technology may allow "eye-opening" possibilities in diagnosing/discovering vision related problems and diseases for ophthalmology and optometry. The study will facilitate the development and commercialization of a new generation of digital ophthalmoscopes. The Ottawa partner company Annidis will strengthen it's position as an innovation and market leader in that field and in turn increase revenue and job creation for a Canadian company.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of PEX Plumbing and Hydronic System Efficiency and Durability
Drive-By-Wire Conversion for Autonomous Patrol Vehicle
Software tools for automated identification and tracking of retinal pathologies
Intelligent mobile agent for the Industrial Internet of Things workforce
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: